Compounds > quercetin 3-o-glucoside-7-o-rhamnoside
Page last updated: 2024-11-13
quercetin 3-o-glucoside-7-o-rhamnoside
Description
quercetin 3-O-glucoside-7-O-rhamnoside: sedative from Tilia petiolaris; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
petiolaroside : A quercetin O-glucoside that is quercetin attached to beta-D-glucopyranosyl residue at position 3 and a alpha-L-rhamnopyranosyl residue at position 7 via glycosidic linkages. Isolated from the aerial parts of Delphinium staphisagria, it exhibits trypanocidal activity. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|
| Delphinium | genus | A plant genus of the family RANUNCULACEAE. Members contain ACONITINE and other diterpenoid alkaloids.[MeSH] | Ranunculaceae | The buttercup plant family of the order RANUNCULALES, class MAGNOLIOPSIDA. The leaves are usually alternate and stalkless. The flowers usually have two to five free sepals and may be radially symmetrical or irregular.[MeSH] |
| Tilia | genus | A plant genus of the family TILIACEAE. Some species in this genus are called Limetree which is nearly the same as the common name for lime (CITRUS AURANTIIFOLIA). Some people are allergic to the POLLEN.[MeSH] | Malvaceae | The mallow family of the order MALVALES, subclass Dilleniidae, class Magnoliopsida. The common names of hollyhock and mallow are used for several genera of Malvaceae.[MeSH] |
| Delphinium staphisagria | species | [no description available] | Ranunculaceae | The buttercup plant family of the order RANUNCULALES, class MAGNOLIOPSIDA. The leaves are usually alternate and stalkless. The flowers usually have two to five free sepals and may be radially symmetrical or irregular.[MeSH] |
Cross-References
Synonyms (15)
| Synonym |
|---|
| petiolaroside |
| 18016-58-5 |
| vincetoxicoside a |
| 7-((6-deoxy-alpha-l-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-3-(beta-d-glucopyranosyloxy)-5-hydroxy-4h-1-benzopyran-4-one |
| quercetin-3-o-beta-d-glucopyranoside-7-o-alpha-l-rhamnopyranoside |
| 7-[(6-deoxy-alpha-l-mannopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4h-chromen-3-yl beta-d-glucopyranoside |
| CHEBI:67931 |
| quercetin 3-o-glucoside-7-o-rhamnoside |
| quercetin-3-o-b-glucosyl-7-o-a-rhamnoside |
| 2-(3,4-dihydroxyphenyl)-5-hydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one |
| DTXSID10936841 |
| Q23418292 |
| quercetin3-o-glucoside-7-o-rhamnoside |
| AKOS040760660 |
| FS-7101 |
Roles (2)
| Role | Description |
|---|
| trypanocidal drug | A drug used to treat or prevent infections caused by protozoal organisms belonging to the suborder Trypanosomatida. |
| plant metabolite | Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (3)
| Class | Description |
|---|
| quercetin O-glucoside | A quercetin O-glycoside that is an O-glucosylated derivative of quercetin. |
| trihydroxyflavone | Any hydroxyflavone carrying three hydroxy groups at unspecified positions. |
| beta-D-glucoside | Any D-glucoside in which the anomeric centre has beta-configuration. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 20.23
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 20.23 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 5.08 (4.65) | | Search Engine Demand Index | 13.88 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |